Cargando…
BSCI-02. METPlatform identifies brain metastasis vulnerabilities and predicts patient response to therapy
The diagnosis of brain metastasis involves high morbidity and mortality and remains an unmet clinical need in spite of being the most common tumor in the brain. Exclusion of these cancer patients from clinical trials is a major cause of their limited therapeutic options. We report a novel drug-scree...
Autores principales: | Zhu, Lucía, Blanco-Aparicio, Carmen, Bertero, Luca, Soffietti, Riccardo, Weiss, Tobias, Muñoz, Javier, Sepúlveda, Juan Manuel, Weller, Michael, Pastor, Joaquín, Valiente, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351295/ http://dx.doi.org/10.1093/noajnl/vdab071.001 |
Ejemplares similares
-
42. IDENTIFICATION OF BRAIN METASTASIS VULNERABILITIES USING METPLATFORM
por: Zhu, Lucía, et al.
Publicado: (2020) -
BSCI-23 ANEUPLOIDY PROFILING IN GLIOBLASTOMA IDENTIFIES MECHANISMS OF DISEASE PROGRESSION AND TREATMENT VULNERABILITIES
por: Jermakowicz, Anna, et al.
Publicado: (2022) -
BSCI-19. Therapeutic intervention of lung-, breast-, and melanoma-brain metastasis
por: Kieliszek, Agata, et al.
Publicado: (2021) -
BSCI-01. Small RNAseq analysis of microRNAs in brain metastasis
por: Jancalek, Radim, et al.
Publicado: (2021) -
BSCI-10. Invasive growth of brain metastases is driven by cancer cell-pSTAT3+ reactive astrocyte crosstalk
por: Dankner, Matthew, et al.
Publicado: (2021)